
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bentonite
Therapeutic Area : Immunology
Study Phase : Approved FDF
Sponsor : Altamira Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Altamira Extends Bentrio Deal with Pharma Nordic To Sweden and Denmark
Details : Under the agreement, Pharma Nordic will market and commercialize Bentrio (bentonite), a nasal spray for protection against airborne allergens, in Sweden and Denmark.
Product Name : Bentrio
Product Type : Miscellaneous
Upfront Cash : Undisclosed
August 23, 2024
Lead Product(s) : Bentonite
Therapeutic Area : Immunology
Highest Development Status : Approved FDF
Sponsor : Altamira Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bentonite
Therapeutic Area : Immunology
Study Phase : Approved FDF
Sponsor : Altamira Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the agreement, Pharma Nordic will market and commercialize Bentrio (bentonite), a nasal spray for protection against airborne allergens, in Norway and potentially further Scandinavian countries.
Product Name : Bentrio
Product Type : Miscellaneous
Upfront Cash : Undisclosed
July 20, 2023
Lead Product(s) : Bentonite
Therapeutic Area : Immunology
Highest Development Status : Approved FDF
Sponsor : Altamira Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
